Stem cells regenerating cornea

New Hope for Vision: Stem Cell Breakthrough in Lacrimal Canals

Author's portrait.
Nico Varela in Health & Wellness December 2025 • 4 min read.

"Researchers discover a novel source of stem cells within the lacrimal canal, offering a promising new approach to treating limbal stem cell deficiency (LSCD) and restoring corneal health."


Vision, the ability to perceive the world in its vibrant detail, relies on the clear and healthy cornea. This transparent tissue, covering the front of the eye, focuses light and allows us to see. The cornea's surface is protected by the corneal epithelium, which constantly regenerates, requiring a continuous supply of new cells.

Epithelial stem cells are essential for this regeneration, acting as a reliable source of new cells. These stem cells reside in a specialized environment called the "niche", maintaining the cornea's health. However, when these stem cells are damaged or deficient, a condition known as limbal stem cell deficiency (LSCD) arises, potentially leading to vision loss.

LSCD is caused by various factors, including chemical burns, genetic conditions, and autoimmune disorders. Traditionally, treatments involve transplanting limbal stem cells from a healthy donor eye, which is limited by the availability of donor tissue. Now, a new study published in the International Journal of Medical Sciences offers a promising alternative: utilizing stem cells harvested from the lacrimal canal.

Lacrimal Canal Stem Cells: A Novel Resource for Corneal Repair?

Stem cells regenerating cornea

The groundbreaking research, led by Weikun Hu and Gui-Gang Li, focuses on isolating and characterizing stem cells from the human lacrimal canaliculus, the small canal that drains tears from the eye. The study proposes that these lacrimal canal epithelial stem cells (LCESCs) can be a viable source for treating LSCD, potentially overcoming the limitations of traditional limbal stem cell transplantation.

To investigate this potential, the researchers examined lacrimal canal tissue from patients with LSCD and cadaveric eyelids. They used a meticulous approach, combining lacrimal endoscopy, specialized cell separation techniques, and advanced cell culture methods to isolate and expand LCESCs in vitro (in the lab). The key steps in their method included:

  • Tissue Extraction: Carefully separating lacrimal canal tissue under an operating microscope, using a lacrimal probe as a guide.
  • Collagenase Digestion: Breaking down the tissue with collagenase A to release clusters of epithelial cells.
  • Cell Separation: Further digestion with trypsin/EDTA to obtain single cells for culture.
  • Cell Culture: Growing the cells on Matrigel-coated plates in a specialized medium (MESCM) to promote stem cell expansion.
  • Characterization: Identifying stem cell markers using immunostaining and assessing colony-forming efficiency.
The results of this study were remarkable. The researchers successfully isolated LCESCs, demonstrating that these cells possess stem cell characteristics similar to those of limbal stem cells (LSCs). Notably, LCESCs exhibited a higher colony-forming efficiency compared to LSCs, indicating their robust regenerative potential. These findings suggest that LCESCs can be a promising resource for LSC reconstruction in LSCD patients.

A Brighter Future for Corneal Regeneration?

This study opens exciting new avenues for treating LSCD and other corneal diseases. By demonstrating that LCESCs can be isolated and expanded, the researchers have identified a readily accessible source of stem cells for corneal repair. While further research is needed to optimize the ex vivo expansion of LCESCs and to develop effective transplantation techniques, this discovery offers a beacon of hope for individuals suffering from vision loss due to corneal damage. The future of corneal regeneration may very well lie within the tiny canals that keep our eyes moist and healthy.

About this Article -

This article was crafted using a human-AI hybrid and collaborative approach. AI assisted our team with initial drafting, research insights, identifying key questions, and image generation. Our human editors guided topic selection, defined the angle, structured the content, ensured factual accuracy and relevance, refined the tone, and conducted thorough editing to deliver helpful, high-quality information.See our About page for more information.

Everything You Need To Know

1

What is the role of the cornea in vision?

The cornea, a transparent tissue covering the front of the eye, is vital for focusing light and enabling clear vision. The corneal epithelium, which protects the cornea's surface, constantly regenerates with the help of epithelial stem cells residing in a specialized environment called the 'niche'. This continuous regeneration ensures the cornea's health and transparency, which are essential for vision.

2

What causes limbal stem cell deficiency (LSCD) and how does it affect vision?

Limbal stem cell deficiency (LSCD) occurs when the epithelial stem cells, responsible for regenerating the cornea, are damaged or deficient. This deficiency can result from chemical burns, genetic conditions, or autoimmune disorders, leading to impaired corneal regeneration and potential vision loss. LSCD disrupts the cornea's ability to maintain a healthy surface, impacting its transparency and function.

3

What are lacrimal canal epithelial stem cells (LCESCs) and why are they important?

Lacrimal canal epithelial stem cells (LCESCs) are stem cells harvested from the lacrimal canaliculus, the small canal that drains tears from the eye. These LCESCs hold promise as a viable source for treating limbal stem cell deficiency (LSCD). They offer a potential alternative to traditional limbal stem cell transplantation by providing a readily accessible source of cells for corneal repair. The significance of LCESCs lies in their regenerative potential and ability to overcome the limitations of donor tissue availability.

4

Can you describe the method used to isolate and expand lacrimal canal epithelial stem cells (LCESCs)?

The process involves several key steps: first, lacrimal canal tissue is carefully extracted. Next, collagenase digestion breaks down the tissue to release clusters of epithelial cells, followed by further digestion with trypsin/EDTA to obtain single cells for culture. These cells are then grown on Matrigel-coated plates in a specialized medium (MESCM) to promote stem cell expansion. Finally, stem cell markers are identified using immunostaining, and colony-forming efficiency is assessed to confirm their regenerative potential. This method ensures the isolation and expansion of LCESCs for potential therapeutic use.

5

What were the key findings of this study and what are the implications for treating corneal diseases?

This research demonstrated that lacrimal canal epithelial stem cells (LCESCs) can be isolated and expanded, possessing stem cell characteristics similar to limbal stem cells (LSCs). Notably, LCESCs exhibited a higher colony-forming efficiency compared to LSCs, indicating their robust regenerative potential. The implications are significant because this finding suggests that LCESCs can be a promising resource for LSC reconstruction in LSCD patients, offering a new avenue for treating corneal diseases and vision loss.

Newsletter Subscribe

Subscribe to get the latest articles and insights directly in your inbox.